These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 27193446)
41. A novel ultra high-throughput 16S rRNA gene amplicon sequencing library preparation method for the Illumina HiSeq platform. de Muinck EJ; Trosvik P; Gilfillan GD; Hov JR; Sundaram AYM Microbiome; 2017 Jul; 5(1):68. PubMed ID: 28683838 [TBL] [Abstract][Full Text] [Related]
42. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss. Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants. Shin S; Hwang IS; Lee ST; Choi JR Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479 [TBL] [Abstract][Full Text] [Related]
44. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy. Hagemann IS; Cottrell CE; Lockwood CM Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712 [TBL] [Abstract][Full Text] [Related]
45. [Detection of pathogenic mutations in Marfan syndrome by targeted next-generation semiconductor sequencing]. Lu C; Wu W; Xiao J; Meng Y; Zhang S; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Jun; 30(3):301-4. PubMed ID: 23744319 [TBL] [Abstract][Full Text] [Related]
47. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627 [TBL] [Abstract][Full Text] [Related]
48. RNA sequencing and quantitation using the Helicos Genetic Analysis System. Raz T; Causey M; Jones DR; Kieu A; Letovsky S; Lipson D; Thayer E; Thompson JF; Milos PM Methods Mol Biol; 2011; 733():37-49. PubMed ID: 21431761 [TBL] [Abstract][Full Text] [Related]
49. Artifactual mutations resulting from DNA lesions limit detection levels in ultrasensitive sequencing applications. Arbeithuber B; Makova KD; Tiemann-Boege I DNA Res; 2016 Dec; 23(6):547-559. PubMed ID: 27477585 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach. Hagemann IS; O'Neill PK; Erill I; Pfeifer JD Cancer Genet; 2015 Sep; 208(9):441-7. PubMed ID: 26227479 [TBL] [Abstract][Full Text] [Related]
51. Detection of a novel intragenic rearrangement in the creatine transporter gene by next generation sequencing. Yu H; van Karnebeek C; Sinclair G; Hill A; Cui H; Zhang VW; Wong LJ Mol Genet Metab; 2013 Dec; 110(4):465-71. PubMed ID: 24140398 [TBL] [Abstract][Full Text] [Related]
52. Next-Generation Sequencing in Diagnostic Pathology. Ilyas M Pathobiology; 2017; 84(6):292-305. PubMed ID: 29131018 [TBL] [Abstract][Full Text] [Related]
53. PCR-Free Enrichment of Mitochondrial DNA from Human Blood and Cell Lines for High Quality Next-Generation DNA Sequencing. Gould MP; Bosworth CM; McMahon S; Grandhi S; Grimberg BT; LaFramboise T PLoS One; 2015; 10(10):e0139253. PubMed ID: 26488301 [TBL] [Abstract][Full Text] [Related]
54. The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China. Zhang R; Ding J; Han Y; Yi L; Xie J; Yang X; Fan G; Wang G; Hao M; Zhang D; Zhang K; Lin G; Li J Oncotarget; 2016 Sep; 7(36):58500-58515. PubMed ID: 27542269 [TBL] [Abstract][Full Text] [Related]
57. Next-generation sequencing for high-throughput molecular ecology: a step-by-step protocol for targeted multilocus genotyping by pyrosequencing. Puritz JB; Toonen RJ Methods Mol Biol; 2013; 1006():89-99. PubMed ID: 23546785 [TBL] [Abstract][Full Text] [Related]
58. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance. Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176 [TBL] [Abstract][Full Text] [Related]
59. [Molecular diagnostics in pathology]. Stenzinger A; Penzel R; Endris V; Weichert W Dtsch Med Wochenschr; 2013 May; 138(20):1061-8. PubMed ID: 23670263 [TBL] [Abstract][Full Text] [Related]
60. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Costello M; Pugh TJ; Fennell TJ; Stewart C; Lichtenstein L; Meldrim JC; Fostel JL; Friedrich DC; Perrin D; Dionne D; Kim S; Gabriel SB; Lander ES; Fisher S; Getz G Nucleic Acids Res; 2013 Apr; 41(6):e67. PubMed ID: 23303777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]